C12N 5/0643
Osteoclasts
Official title: {Osteoclasts}
C12N5/0643 (Osteoclasts) appears on 18 US grants and 25 published applications in this corpus.
Search patents in C12N- Granted patents
- 18
- Published applications
- 25
- Assignees
- 25
- Inventors
- 57
- Latest grant
- 6 Jun 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 2 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 3 |
| 2005 | 1 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 2 |
| 2009 | 2 | 1 |
| 2010 | 0 | 2 |
| 2011 | 0 | 4 |
| 2012 | 2 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 2 |
| 2019 | 0 | 3 |
| 2020 | 1 | 2 |
| 2021 | 2 | 1 |
| 2022 | 0 | 0 |
| 2023 | 1 | 1 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Method of selectively differentiating undifferentiated macrophage into M1 macrophage6 Jun 2023US 11,667,891 B2Korea Institute of Science and Technology
- Lab-on-a-chip (LOC) for biomimetic bone remodeling analysis28 Dec 2021US 11,207,676 B2The University of Akron
- Tissue-engineered three-dimensional model for tumor analysis5 Jan 2021US 10,883,083 B2The Trustees of Columbia University in the City of New York
- Phage-based matrix for inducing stem cell differentiation and method for preparing the same31 Mar 2020US 10,604,737 B2Pusan National University Industry-University Cooperation Foundation
- Generation of mature myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived lin-CD34+CD43+CD45+progenitors30 Sep 2014US 8,846,395 B2Wisconsin Alumni Research Foundation
- Compositions and methods for activating nk cells13 Feb 2025US 2025/0049859 A1The Regents of the University of California
- Compositions and methods for activating nk cells23 May 2024US 2024/0165152 A1The Regents of the University of California
- Bioactive Collagen Peptides, Method Of Production Thereof, And Use Thereof23 Nov 2023US 2023/0374112 A1Corporation Genacol Canada Inc.
- Tissue-engineered three-dimensional model for tumor analysis8 Apr 2021US 2021/0102170 A1The Trustees of Columbia University in the City of New York
- Method for the selective differentiation into m1 macrophages31 Dec 2020US 2020/0407684 A1Korea Institute of Science and Technology
Most cited
By later US patents
- Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells94US 6,255,112 B1Osiris Therapeutics, Inc. · 2001
- Immortalized dendritic cells31US 5,648,219 AZymoGenetics, Inc. · 1997
- Preparation of immortalized cells11US 5,830,682 AZymoGenetics, Inc. · 1998
- 2′,4′-dichloro-biphenyl-4-yl-hydroxy-ketones and related compounds and their use as therapeutic agents11US 7,560,597 B2The University Court of the University of Aberdeen · 2009
- Preparation of immortalized cells4US 5,683,906 AZymoGenetics, Inc. · 1997